Let's Connect

Our Experts Respond Within 24 hours

    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.
    ╳

    Extensive Project Portfolio with Global Sponsors

    Palleos’s comprehensive CRO services portfolio includes over 420 clinical trials in Phases I-IV in 29 therapeutic areas.
    Request a Proposal

    Palleos has been at the forefront of clinical trials since 2005, actively leading projects in Europe and CIS countries, and providing comprehensive support to clients from research planning to drug registration. With over 420 full-service projects and individual clinical development services completed, Palleos has a deep understanding of the clinical trial process, enabling to identify potential risks and mitigate them at the earliest stage of project planning.

    We are proud to offer expertise
    in   29 therapeutic areas
    as a mid-size CRO

    Oncology

    118
    studies

    Respiratory Diseases​

    57
    studies

    Infectious Diseases

    49
    studies

    Bioequivalence

    47
    studies

    Neurology

    41
    studies

    Cardiovascular

    33
    studies

    Gastroenterology

    31
    studies

    Skin Diseases

    29
    studies

    Endocrinology

    24
    studies

    Rheumatology​

    24
    studies

    Urology​

    23
    studies

    Surgery

    22
    studies

    Pediatrics

    21
    studies

    Women’s Health

    21
    studies

    Psychiatry​

    17
    studies

    Ear/Nose/Throat ​

    16
    studies

    Ophthalmology​

    15
    studies

    Nephrology​

    12
    studies

    Dental​

    4
    studies

    Therapeutic Experience Hub

    Select a type of study
    Select Therapeutic Area
    Phase
    IndicationGroupPhase / ClassTypeYearTherapeutic areas
    NSCLC​Drug​III​Interventional​2024​Oncology
    Breast Cancer​Drug​N/A​Non-interventional​2023​Oncology
    Lung Cancer​Drug​I​Interventional​2023​Oncology
    Breast Cancer​Device​II(b)​Interventional​2022​Oncology
    Solid Tumors​Drug​IV​Non-interventional​2022​Oncology
    Head & Neck Cancer​Drug​III​Interventional​2022​Oncology
    Breast Cancer​Drug​II​Interventional​2022​Oncology
    Breast Cancer​Drug​III​Interventional​2021​Oncology
    Breast Cancer​Drug​II​Interventional​2020​Oncology
    Solid tumors​Drug​III​Interventional​2020​Oncology
    Follicular Lymphoma​Drug​III​Interventional​2020​Oncology
    Chronic Myeloid Leukemia​Drug​III​Interventional​2019​Oncology
    Breast Cancer​Drug​III​Interventional​2019​Oncology
    Chronic Myeloid Leukosis​Drug​II​Interventional​2019​Oncology
    NSCLC​Drug​III​Interventional​2018​Oncology
    Squamous Cell Cancer ​Drug​II​Interventional​2018​Oncology
    NSCLC (with high PD-L1 expression)​Drug​I​Interventional​2018​Oncology
    Advanced Solid Tumor​Drug​I​Interventional​2018​Oncology
    Breast Cancer​Drug​I​Interventional​2017​Oncology
    Breast Cancer​Drug​IV​Interventional​2017​Oncology
    Breast Cancer​Drug​II​Interventional​2017​Oncology
    Solid Tumors​Drug​I​Interventional​2017​Oncology
    Hematological Cancers ​Drug​I​Interventional​2017​Oncology
    EGFR-Mutant NSCLC​Drug​II​Interventional​2017​Oncology
    Non-Hodgkin’s Lymphoma​Drug​II​Interventional​2017​Oncology
    Breast cancer​Device​IVD​Interventional​2017​Oncology
    Recurrent Glioblastoma​Drug​II​Interventional​2017​Oncology
    Chronic Lymphocytic Leukemia ​Drug​N/A​Non-interventional​2017​Oncology
    Colorectal Cancer​Drug​III​Interventional​2017​Oncology
    Breast Cancer ​Drug​II​Interventional​2016​Oncology
    Unspecified Adult Solid Tumors​Drug​I​Interventional​2016​Oncology
    Chronic Lymphocytic Leukemia​Drug​III​Interventional​2016​Oncology
    Breast Cancer ​Drug​III​Interventional​2016​Oncology
    Idiopathic Pulmonary Fibrosis​Drug​II​Interventional​2016​Oncology
    Breast Cancer ​Drug​II​Interventional​2015​Oncology
    Breast Cancer ​Drug​II​Interventional​2015​Oncology
    Breast Cancer ​Drug​N/A​Non-interventional​2015​Oncology
    Chronic Myeloid Leukemia​Drug​I​Interventional​2015​Oncology
    Breast Cancer​Drug​III​Interventional​2015​Oncology
    Breast Cancer​Drug​II​Interventional​2015​Oncology
    Locally Advanced Epithelial Ovarian Cancer, Primary​Drug​II​Interventional​2015​Oncology
    Breast Cancer​Drug​III​Interventional​2015​Oncology
    Colorectal Cancer​Drug​II​Interventional​2015​Oncology
    NSCLC​Drug​III​Interventional​2015​Oncology
    Chronic Myeloid Leukemia​Drug​II​Interventional​2015​Oncology
    Сhronic Myeloid Leukemia​Drug​II​Interventional​2015​Oncology
    Bone Metastases of Breast Cancer ​Drug​II​Interventional​2015​Oncology
    Breast Cancer​Drug​II​Interventional​2014​Oncology
    Breast Cancer​Drug​N/A​Non-interventional​2014​Oncology
    Breast Cancer​Drug​N/A​Non-interventional​2014​Oncology
    B-cell Lymphoma​Drug​III​Interventional​2014​Oncology
    Metastatic Colon Cancer ​Drug​III​Interventional​2014​Oncology
    Solid Tumors​Drug​I​Interventional​2014​Oncology
    Breast Cancer​Drug​I​Interventional​2014​Oncology
    Acute Myeloid Leukosis​Drug​I​Interventional​2014​Oncology
    Advanced Melanoma​Drug​I​Interventional​2014​Oncology
    Breast Cancer​Drug​II​Interventional​2013​Oncology
    Breast Cancer​Drug​II​Interventional​2013​Oncology
    Breast Cancer​Drug​II​Interventional​2013​Oncology
    NSCLC ​Drug​IV (post-marketing)​Non-interventional​2013​Oncology
    Breast Cancer​Drug​IV (post-marketing)​Non-interventional​2013​Oncology
    Endometrial Carcinoma​Drug​II​Interventional​2013​Oncology
    Ovarian Cancer ​Drug​I​Interventional​2013​Oncology
    Metastatic Cancer​Drug​I​Interventional​2013​Oncology
    Solid Tumors​Drug​I​Interventional​2013​Oncology
    Endometrial Carcinoma ​Drug​II​Interventional​2013​Oncology
    Advanced Melanoma​Drug​I​Interventional​2013​Oncology
    Advanced Melanoma​Drug​I​Interventional​2013​Oncology
    Breast Cancer​Drug​III​Interventional​2012​Oncology
    Breast Cancer​Drug​III​Interventional​2012​Oncology
    Breast Cancer​Drug​II​Interventional​2012​Oncology
    Breast Cancer​Drug​II​Interventional​2012​Oncology
    Acute Myeloid Leukemia​Drug​II​Interventional​2012​Oncology
    Multiple Myeloma​Drug​III​Interventional​2012​Oncology
    Hepatocellular Carcinoma ​Drug​N/A​Non-interventional​2012​Oncology
    Breast Cancer​Drug​II​Interventional​2011​Oncology
    Bladder Cancer​Drug​II​Interventional​2011​Oncology
    Locally Advanced Pancreatic Cancer​Drug​II​Interventional​2011​Oncology
    Metastatic Breast Cancer​Drug​II​Interventional​2011​Oncology
    Breast Cancer​Drug​II​Interventional​2011​Oncology
    Multiple Myeloma​Drug​III​Interventional​2011​Oncology
    Solid Tumors​Drug​I​Interventional​2011​Oncology
    Colorectal Cancer​Drug​III​Interventional​2010​Oncology
    Colorectal Cancer​Drug​II​Interventional​2010​Oncology
    Solid Tumors​Drug​II​Interventional​2010​Oncology
    Breast Cancer​Drug​II​Interventional​2010​Oncology
    Endometrial Carcinoma​Drug​II​Interventional​2010​Oncology
    Colorectal Cancer​Drug​III​Interventional​2010​Oncology
    Head and Neck Cancer​Drug​III​Interventional​2010​Oncology
    Breast Cancer​Drug​II​Interventional​2009​Oncology
    Breast Cancer​Drug​III​Interventional​2009​Oncology
    Prostate Cancer​Drug​II​Interventional​2008​Oncology
    Pain​Drug​II​Interventional​2008​Oncology
    Bone Metastases, Pain​Drug​II​Interventional​2008​Oncology
    Ovarian Cancer​Drug​III​Interventional​2008​Oncology
    Solid Tumors​Drug​I​Interventional​2008​Oncology
    Prostate Cancer​Drug​II​Interventional​2008​Oncology
    Prostate Cancer ​Drug​II​Interventional​2008​Oncology
    Acute Myeloid Leukosis​Drug​II​Interventional​2007​Oncology
    Hepatic Metastases​Drug​II​Interventional​2007​Oncology
    Breast Cancer, Neutropenia​Drug​III​Interventional​2007​Oncology
    Breast Cancer​Drug​II​Interventional​2007​Oncology
    Prostate Cancer​Drug​II​Interventional​2007​Oncology
    Breast Cancer​Drug​II​Interventional​2007​Oncology
    Pain​Drug​II​Interventional​2007​Oncology
    Prostate Cancer​Drug​III​Interventional​2006​Oncology
    Immunotherapy in Renal Cell Carcinoma​Drug​III​Interventional​2005​Oncology
    T-cell Leukemia​Drug​II​Interventional​2005​Oncology
    Ischemic stroke​Device​III​Interventional​2024​Cardiovascular​
    Venous Thrombosis​Drug​II​Interventional​2018​Cardiovascular​
    Atherosclerosis ​Drug​II​Interventional​2018​Cardiovascular​
    Atherosclerosis ​Drug​III​Interventional​2017​Cardiovascular​
    Arterial Hypertension​Drug​III​Non-interventional​2017​Cardiovascular​
    Cardiac Monitoring​Drug​III​Non-interventional​2015​Cardiovascular​
    Heart Failure​Drug​III​Interventional​2014​Cardiovascular​
    Deep Vein Thrombosis​Drug​III​Interventional​2014​Cardiovascular​
    LV Insufficiency​Drug​IV (post-marketing)​Interventional​2013​Cardiovascular​
    Arterial Hypertension​Drug​IV (post-marketing)​Non-interventional​2013​Cardiovascular​
    Essential Hypertension ​Drug​III​Interventional​2013​Cardiovascular​
    Dislipidemia​Drug​I​Interventional​2013​Cardiovascular​
    Prophylaxis of Thromboembolic Complication in Knee​Drug​II​Interventional​2013​Cardiovascular​
    Essential Hypertension ​Drug​Pre-clinical​Interventional​2013​Cardiovascular​
    Thromboembolic Events​Drug​IV (post-marketing)​Non-interventional​2012​Cardiovascular​
    Atrial Fibrillation​Drug​IV (post-marketing)​Non-interventional​2012​Cardiovascular​
    Coronary Artery Disease​Drug​III​Interventional​2012​Cardiovascular​
    Deep Vein Thrombosis​Drug​III​Interventional​2012​Cardiovascular​
    Stable Angina​Drug​IV (post-marketing)​Interventional​2011​Cardiovascular​
    Isolated Systolic Hypertension​Drug​III​Interventional​2011​Cardiovascular​
    Brain Vessel Aneurism Rupture​Drug​III​Interventional​2008​Cardiovascular​
    Acute Myocardial Infarction​Drug​III​Interventional​2007​Cardiovascular​
    Acute Heart Failure​Drug​III​Interventional​2006​Cardiovascular​
    Healthy Volunteers​Drug​BE study​Interventional​2024​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2024​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2022​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2022​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2022​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2021​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2021​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2021​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2021​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2020​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2020​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2020​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2020​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2020​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2019​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2018​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2016​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2016​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2016​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2016​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2016​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2015​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2015​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2015​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2015​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2015​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2013​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2013​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2012​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2012​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2012​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2012​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2011​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2011​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2011​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2011​Bioequivalence
    Healthy Volunteers​Drug​BE study​Interventional​2007​Bioequivalence
    Acute back pain​Drug​III​Interventional​2021​Neurology
    Headache/Migraine​Device​II(b)​Interventional​2020​Neurology
    Acute back pain​Drug​III​Interventional​2020​Neurology
    Headache/Migraine​Drug​N/A​Interventional​2020​Neurology
    Acute Back Pain​Drug​III​Interventional​2019​Neurology
    Back Pain​Drug​III​Interventional​2019​Neurology
    Chronic Discogenic Low Back Pain​Drug​II​Interventional​2019​Neurology
    Musculo-skeletal Injuries​Drug​III​Interventional​2019​Neurology
    Multiple Sclerosis​Drug​III​Interventional​2019​Neurology
    Pain​Drug​IV (post-marketing)​Interventional​2019​Neurology
    Healthy Volunteers​Drug​I​Interventional​2018​Neurology
    Craniocerebral Injury​Drug​III​Interventional​2018​Neurology
    Diabetic Polyneuropathy​Drug​II​Interventional​2017​Neurology
    Post Traumatic Inflamation of Soft Tissues​Drug​III​Interventional​2017​Neurology
    Post Traumatic Inflamation of Soft Tissues​Drug​II​Interventional​2017​Neurology
    Acute Dental Pain​Drug​III​Interventional​2016​Neurology
    Acute Non-specific Lower Back Pain​Drug​III​Interventional​2016​Neurology
    Meniere’s Disease and/or Vestibular Vertigo​Drug​III​Interventional​2016​Neurology
    Spondylarthritis (Ankylosing Spondylitis and Psori)​Drug​IV (post-marketing)​Non-interventional​2016​Neurology
    Mild Cognitive Impairment​Drug​III​Interventional​2015​Neurology
    Vestibular Vertigo​Drug​III​Interventional​2014​Neurology
    Hypoxic Central Nervous System Injury​Drug​III​Interventional​2014​Neurology
    Back Pain​Drug​III​Interventional​2014​Neurology
    Alzheimer Disease​Drug​IV (post-marketing)​Interventional​2014​Neurology
    Multiple Sclerosis​Drug​III​Interventional​2013​Neurology
    Multiple Sclerosis​Drug​IV (post-marketing)​Non-interventional​2012​Neurology
    Multiple Sclerosis​Drug​I​Interventional​2012​Neurology
    Vascular Dementia​Drug​N/A​Interventional​2012​Neurology
    Pregnancy Exposure​Drug​IV (post-marketing)​Non-interventional​2012​Neurology
    Back Pain ​Drug​III​Interventional​2011​Neurology
    Brain Vessel Aneurism Rupture​Drug​III​Interventional​2008​Neurology
    COPD​Device​I​Non-interventional​2022​Respiratory Diseases​
    Influenza vaccine​Drug​III​Interventional​2022​Respiratory Diseases​
    Chronic obstructive pulmonary disease​Drug​N/A​Non-interventional​2022​Respiratory Diseases​
    COVID-19 treatment​Drug​III​Interventional​2022​Respiratory Diseases​
    Post-COVID-19 pneumofibrosis​Drug​III​Interventional​2021​Respiratory Diseases​
    COVID-19 Vaccine​Drug​III​Interventional​2021​Respiratory Diseases​
    Acute Respiratory Viral Infection​Drug​III​Interventional​2020​Respiratory Diseases​
    COVID-19 vaccine​Drug​III​Interventional​2020​Respiratory Diseases​
    COVID-19 vaccine​Drug​III​Interventional​2020​Respiratory Diseases​
    COVID-19 vaccine​Drug​III​Interventional​2020​Respiratory Diseases​
    Nosocomial Pneumonia​Drug​III​Interventional​2019​Respiratory Diseases​
    Acute Respiratory Viral Infection​Drug​III​Interventional​2019​Respiratory Diseases​
    Nosocomial Pneumonia​Drug​III​Interventional​2019​Respiratory Diseases​
    Acute Respiratory Viral Infection​Drug​III​Interventional​2018​Respiratory Diseases​
    Influenza vaccine​Drug​III​Interventional​2017​Respiratory Diseases​
    Tuberculosis ​Drug​I​Interventional​2017​Respiratory Diseases​
    Idiopathic Pulmonary Fibrosis​Drug​III​Interventional​2017​Respiratory Diseases​
    Acute Upper Respiratory Infections​Drug​III​Interventional​2017​Respiratory Diseases​
    Influenza vaccine​Drug​I​Interventional​2016​Respiratory Diseases​
    Cough on Acute Upper Respiratory Infection​Drug​III​Interventional​2016​Respiratory Diseases​
    Tuberculosis​Drug​II​Interventional​2016​Respiratory Diseases​
    Influenza vaccine​Drug​II​Interventional​2016​Respiratory Diseases​
    Tuberculosis​Drug​II​Interventional​2016​Respiratory Diseases​
    Influenza vaccine​Drug​IV​Non-interventional​2016​Respiratory Diseases​
    Idiopathic Pulmonary Fibrosis​Drug​II​Interventional​2016​Respiratory Diseases​
    Influenza vaccine​Drug​II​Interventional​2016​Respiratory Diseases​
    Tuberculosis​Drug​I​Interventional​2015​Respiratory Diseases​
    Renal Colics​Drug​III​Interventional​2015​Respiratory Diseases​
    Sore Throat​Drug​III​Interventional​2015​Respiratory Diseases​
    Chronic Obstructive Pulmonary Disease (COPD)​Drug​II​Interventional​2014​Respiratory Diseases​
    Community Acquired Pneumonia​Drug​III​Interventional​2014​Respiratory Diseases​
    Multiple Drug Resistant Tuberculosis​Drug​IV (post-marketing)​Interventional​2013​Respiratory Diseases​
    Chronic Obstructive Pulmonary Disease​Drug​IV (post-marketing)​Non-interventional​2013​Respiratory Diseases​
    Outpatient Pneumonia​Drug​IV (post-marketing)​Non-interventional​2013​Respiratory Diseases​
    Community Acquired Pneumonia​Drug​III​Interventional​2013​Respiratory Diseases​
    Recurrent Upper Respiratory Tract Infections​Drug​III​Interventional​2013​Respiratory Diseases​
    Mucoviscidosis​Drug​I​Interventional​2013​Respiratory Diseases​
    Non-small Cell Lung and Epithelial Ovarian Cancer​Drug​I​Interventional​2013​Respiratory Diseases​
    Respiratory Tract Infection​Drug​IV (post-marketing)​Non-interventional​2013​Respiratory Diseases​
    Asthma​Drug​III​Interventional​2012​Respiratory Diseases​
    Sore Throat​Drug​III​Non-interventional​2012​Respiratory Diseases​
    Sore Throat​Drug​III​Interventional​2012​Respiratory Diseases​
    Asthma​Drug​III​Interventional​2011​Respiratory Diseases​
    Sore Throat​Drug​II​Interventional​2010​Respiratory Diseases​
    Rhinitis​Drug​IV (post-marketing)​Non-interventional​2010​Respiratory Diseases​
    Acute Bronchitis​Drug​IV (post-marketing)​Non-interventional​2010​Respiratory Diseases​
    Pulmonology/Pediatrics, Bronchitis, Pneumonia, AS​Drug​IV (post-marketing)​Non-interventional​2009​Respiratory Diseases​
    Ulcerative Colitis​Drug​III​Interventional​2022​Gastroenterology​
    Esophagitis​Drug​III​Interventional​2021​Gastroenterology​
    Gastroparesis​Drug​IIb​Interventional​2021​Gastroenterology​
    Ulcerative Colitis (referral)​Drug​III​Interventional​2020​Gastroenterology​
    Ulcerative Colitis​Drug​III​Interventional​2020​Gastroenterology​
    Helicobacter Pylori Infection​Device​I​Interventional​2019​Gastroenterology​
    Gastritis​Drug​I​Interventional​2019​Gastroenterology​
    Dyspepsia​Drug​III​Interventional​2019​Gastroenterology​
    Crohn’s Disease (referral)​Drug​III​Interventional​2019​Gastroenterology​
    Ulcerative Colitis​Drug​III​Interventional​2018​Gastroenterology​
    Acute Hemorrhoids​Drug​III​Interventional​2018​Gastroenterology​
    Ulcerative Colitis​Drug​I​Interventional​2017​Gastroenterology​
    Acute Diarrhea (pediatric)​Drug​III​Interventional​2017​Gastroenterology​
    Ulcerative Proctitis​Drug​II​Interventional​2016​Gastroenterology​
    Ulcerative Proctitis​Drug​II​Interventional​2013​Gastroenterology​
    Biliary Colic​Drug​III​Interventional​2011​Gastroenterology​
    Infant Colic ​Drug​II​Interventional​2011​Gastroenterology​
    Eradication of H. pylori​Drug​II​Interventional​2009​Gastroenterology​
    Hepatic Cirrhosis​Drug​III​Interventional​2009​Gastroenterology​
    Crohn’s Disease​Drug​II​Interventional​2008​Gastroenterology​
    Irritable Bowel Syndrome​Drug​III​Interventional​2007​Gastroenterology​
    Upper Respiratory Tract Infection​Drug​III​Interventional​2022​Infectious Diseases
    COVID-19​Drug​III​Interventional​2022​Infectious Diseases
    COVID-19​Drug​III​Interventional​2022​Infectious Diseases
    Viral Hepatitis​Drug​III​Interventional​2020​Infectious Diseases
    COVID-19 Vaccine​Drug​III​Interventional​2020​Infectious Diseases
    COVID-19 Vaccine​Drug​III​Interventional​2020​Infectious Diseases
    Acute Respiratory Viral Infection​Drug​III​Interventional​2020​Infectious Diseases
    Viral Hepatitis​Drug​III​Interventional​2020​Infectious Diseases
    COVID-19 Vaccine​Drug​III​Interventional​2020​Infectious Diseases
    COVID-19 Vaccine​Drug​III​Interventional​2020​Infectious Diseases
    Urinary Tract Infection​Drug​III​Interventional​2019​Infectious Diseases
    Urinary Tract Infection​Drug​N/A​Non-interventional​2019​Infectious Diseases
    Urinary Tract Infection​Drug​II​Interventional​2019​Infectious Diseases
    Acute Respiratory Viral Infection​Drug​III​Interventional​2018​Infectious Diseases
    Gastrointestinal Infections​Drug​III​Interventional​2018​Infectious Diseases
    Tuberculosis ​Drug​I​Interventional​2017​Infectious Diseases
    Influenza (partial service)​Drug​II​Interventional​2017​Infectious Diseases
    Influenza Vaccine ​Drug​III​Interventional​2017​Infectious Diseases
    Influenza Vaccine ​Drug​I​Interventional​2017​Infectious Diseases
    Chronic HCV Gt1b Infection and Compensated Liver Cirrhosis​Drug​IV​Non-interventional​2017​Infectious Diseases
    Post traumatic inflammation of soft tissues (partial service)​Drug​III​Interventional​2016​Infectious Diseases
    Influenza Vaccine (partial service)​Drug​II​Interventional​2016​Infectious Diseases
    Part of Therapy for HIV Patients​Drug​BE​Interventional​2016​Infectious Diseases
    Cough on Acute Upper Respiratory Infection​Drug​III​Interventional​2016​Infectious Diseases
    Influenza Vaccine​Drug​IV​Non-interventional​2016​Infectious Diseases
    Chronic Hepatitis C​Drug​IV​Non-interventional​2016​Infectious Diseases
    Chronic Hepatitis D​Drug​II​Interventional​2016​Infectious Diseases
    Tuberculosis​Drug​II​Interventional​2016​Infectious Diseases
    HIV​Drug​IV​Non-Interventional​2015​Infectious Diseases
    HIV​Drug​IV​Non-Interventional​2015​Infectious Diseases
    Chronic Hepatitis B​Drug​II​Interventional​2015​Infectious Diseases
    Tuberculosis​Drug​III​Interventional​2014​Infectious Diseases
    HIV ​Drug​II​Interventional​2014​Infectious Diseases
    Complicated Urinary Tract Infections​Drug​III​Interventional​2014​Infectious Diseases
    Respiratory Tract Infection in Pediatrics​Drug​IV​Non-Interventional​2013​Infectious Diseases
    Hepatitis B​Drug​I​Interventional​2013​Infectious Diseases
    Recurrent Upper Respiratory Tract Infections​Drug​III​Interventional​2013​Infectious Diseases
    HBeAg Negative Chronic Hepatitis B​Drug​II​Interventional​2012​Infectious Diseases
    Chronic Hepatitis B​Drug​II​Interventional​2012​Infectious Diseases
    Rheumatoid Arthritis​Drug​III​Interventional​2023​Rheumatology​
    Rheumatoid Arthritis​Drug​I​Interventional​2021​Rheumatology​
    Osteoarthrosis​Drug​III​Interventional​2020​Rheumatology​
    Knee Pain​Drug​III​Interventional​2019​Rheumatology​
    Osteoarthrosis​Drug​IV​Non-Interventional​2017​Rheumatology​
    Spondylarthritis​Drug​IV​Non-interventional​2016​Rheumatology​
    Acute Gout​Drug​II​Interventional​2016​Rheumatology​
    Rheumatoid Arthritis​Drug​III​Interventional​2016​Rheumatology​
    Rheumatoid Arthritis​Drug​III​Interventional​2016​Rheumatology​
    Rheumatoid Arthritis​Drug​III​Interventional​2015​Rheumatology​
    Rheumatoid Arthritis ​Drug​I​Interventional​2015​Rheumatology​
    Rheumatoid Arthritis ​Drug​IV​Interventional​2011​Rheumatology​
    Gout​Drug​III​Interventional​2011​Rheumatology​
    Rheumatoid Arthritis​Drug​II​Interventional​2008​Rheumatology​
    Peritoneal Commissures​Drug​III​Interventional​2019​Surgery
    Intensive Care​Drug​II​Interventional​2017​Surgery
    Acute Dental Pain​Drug​III​Interventional​2016​Surgery
    Anal Fissure​Drug​III​Interventional​2015​Surgery
    Knee Replacement​Drug​III​Interventional​2014​Surgery
    Infusion Therapy​Drug​III​Interventional​2014​Surgery
    Intensive Care​Drug​III​Interventional​2012​Surgery
    Central Catheter’s Maintenance​Drug​III​Interventional​2011​Surgery
    Central Catheter’s Maintenance​Drug​III​Interventional​2011​Surgery
    Wound Healing ​Drug​II​Interventional​2011​Surgery
    Colorectal Anastomosis​Drug​I​Interventional​2010​Surgery
    Major Orthopedic Surgery​Drug​III​Interventional​2010​Surgery
    Diabetic Polyneuropathy​Drug​III​Interventional​2021​Endocrinology
    Diabetic Polyneuropathy​Drug​II​Interventional​2017​Endocrinology
    Diabetes Mellitus​Drug​IV (post-marketing)​Non-interventional​2017​Endocrinology
    Diabetic Neuropathy​Drug​III​Interventional​2014​Endocrinology
    Diabetes Mellitus Type 2​Drug​IV (post-marketing)​Non-interventional​2013​Endocrinology
    Diabetes Mellitus type 2​Drug​I​Interventional​2013​Endocrinology
    Dislipidemia​Drug​I​Interventional​2013​Endocrinology
    Diabetic Foot Ulcer​Drug​N/A​Interventional​2013​Endocrinology
    Parenteral Nutrition​Drug​III​Interventional​2013​Endocrinology
    Parenteral Nutrition​Drug​III​Interventional​2011​Endocrinology
    Ischemic Foot Ulcers​Drug​III​Interventional​2011​Endocrinology
    Diabetes Mellitus​Drug​II​Interventional​2009​Endocrinology
    Hypothyreosis​Drug​IV (post-marketing)​Non-interventional​2009​Endocrinology
    Diabetes Mellitus​Drug​II​Interventional​2008​Endocrinology
    Influenza (vaccine)​Drug​III​Interventional​2022​Pediatrics
    Viral Hepatitis (pediatric)​Drug​III​Interventional​2020​Pediatrics
    Acute Diarrhea​Drug​III​Interventional​2017​Pediatrics
    Influenza Vaccine ​Drug​III​Interventional​2017​Pediatrics
    Recurrent Upper Respiratory Tract Infections​Drug​III​Interventional​2013​Pediatrics
    Acute Otitis​Drug​IV (post-marketing)​Non-interventional​2013​Pediatrics
    Infant Colic​Drug​II​Interventional​2011​Pediatrics
    Intestinal Colics​Drug​IV (post-marketing)​Non-interventional​2010​Pediatrics
    Acute Bronchitis​Drug​IV (post-marketing)​Interventional​2010​Pediatrics
    Bronchitis​Drug​IV (post-marketing)​Non-interventional​2009​Pediatrics
    Nutrition​Drug​III​Interventional​2006​Pediatrics
    Erectile Dysfunction​Device​II(b)​Interventional​2021​Urology​
    Recurrent Vulvovaginal Candidiasis​Drug​III​Interventional​2020​Urology​
    Urinary tract infection​Drug​III​Interventional​2019​Urology​
    Urinary tract infection​Drug​II​Interventional​2019​Urology​
    Urinary tract infection​Drug​N/A​Non-interventional​2019​Urology​
    Erectile Dysfunction​Drug​III​Interventional​2018​Urology​
    Erectile Dysfunction​Drug​III​Interventional​2018​Urology​
    Astenospermia​Drug​II​Interventional​2015​Urology​
    Healthy Volunteers​Drug​I​Interventional​2015​Urology​
    Complicated Urinary Tract Infections​Drug​III​Interventional​2014​Urology​
    Сhronic Prostatitis​Drug​IV (post-marketing)​Non-interventional​2013​Urology​
    Chronic Prostatitis ​Drug​IV (post-marketing)​Non-interventional​2013​Urology​
    Erectile Dysfunction​Drug​III​Interventional​2009​Urology​
    Glaucoma ​Drug​III​Interventional​2018​Ophthalmology​
    Chronic Blepharoconjunctivitis​Drug​III​Interventional​2015​Ophthalmology​
    Corneal Injury​Drug​I​Interventional​2014​Ophthalmology​
    Ocular Inflammation Following Cataract Surgery​Drug​III​Interventional​2012​Ophthalmology​
    Age-related Macular Degeneration​Drug​I​Interventional​2008​Ophthalmology​
    Psoriasis Vulgaris​Drug​III​Interventional​2024​Skin Diseases
    Mycosis​Drug​III​Interventional​2022​Skin Diseases
    Atopic dermatitis​Drug​IV (post-marketing)​Non-Interventional​2021​Skin Diseases
    Moscquito Bites​Drug​III​Interventional​2021​Skin Diseases
    Nail Mycosis​Drug​III​Interventional​2020​Skin Diseases
    Atopic Dermatitis​Drug​II​Interventional​2020​Skin Diseases
    Psoriasis​Drug​III​Interventional​2020​Skin Diseases
    Netherton Syndrome​Drug​III​Interventional​2020​Skin Diseases
    Atopic Dermatitis ​Drug​II​Interventional​2020​Skin Diseases
    Nail Mycosis​Drug​III​Interventional​2020​Skin Diseases
    Nasolabial Folds​Drug​IV (post-marketing)​Interventional​2019​Skin Diseases
    Glabellar Lines​Drug​III​Interventional​2018​Skin Diseases
    Recessive Dystrophic Epidermolysis Bullosa​Drug​I​Interventional​2018​Skin Diseases
    Seborrheic Dermatitis​Drug​III​Interventional​2017​Skin Diseases
    Atopic Eczema ​Drug​III​Interventional​2016​Skin Diseases
    Psoriasis Vulgaris​Drug​I​Interventional​2015​Skin Diseases
    Rosacea​Drug​N/A​Non-interventional​2015​Skin Diseases
    Ischemic Foot Ulcers​Drug​III​Interventional​2011​Skin Diseases
    Acne​Drug​II​Interventional​2006​Skin Diseases
    Meniere’s Disease and/or Vestibular Vertigo​Drug​III​Interventional​2016​Ear/Nose/Throat ​
    Vestibular Vertigo ​Drug​III​Interventional​2014​Ear/Nose/Throat ​
    Acute Otitis ​Drug​IV (Post-marketing)​Interventional​2013​Ear/Nose/Throat ​
    Respiratory Tract Infection ​Drug​IV (post-marketing)​Non-interventional​2013​Ear/Nose/Throat ​
    Sore Throat​Drug​III​Interventional​2013​Ear/Nose/Throat ​
    Rhinitis​Drug​IV (post-marketing)​Non-interventional​2010​Ear/Nose/Throat ​
    Schizophrenia​Drug​III​Interventional​2019​Psychiatry​
    Schizophrenia​Drug​III​Interventional​2017​Psychiatry​
    Mild Cognitive Impairment​Drug​III​Interventional​2015​Psychiatry​
    Schizophrenia ​Drug​III​Interventional​2014​Psychiatry​
    Schizophrenia​Drug​II​Interventional​2014​Psychiatry​
    Anxiety Disorder​Drug​II​Interventional​2012​Psychiatry​
    Alcohol Abuse​Drug​II​Interventional​2012​Psychiatry​
    Polycystic Kidney Disease​Drug​III​Interventional​2022​Nephrology​
    Chronic Kidney Disease​Drug​III​Interventional​2012​Nephrology​
    Dental Replacement​Device​III​Non-interventional​2022​Dental​
    Diseases of Female Genital Tract​Drug​III​Interventional​2023​Women’s Health
    Prevention of Peritoneal Commissures​Drug​III​Interventional​2021​Women’s Health
    Recurrent Vulvovaginal Candidiasis​Drug​III​Interventional​2020​Women’s Health
    Pelvic Inflammatory Disease​Drug​III​Interventional​2020​Women’s Health
    Female Sexual Arousal Disorder​Drug​III​Interventional​2017​Women’s Health
    Primary Dysmenorrhoea​Drug​III​Interventional​2016​Women’s Health
    Healthy volunteers​Drug​I​Interventional​2016​Women’s Health
    Female Sexual Arousal Disorder​Drug​II​Interventional​2015​Women’s Health
    Healthy volunteers​Drug​I​Interventional​2014​Women’s Health
    Vaginitis​Drug​IV (post-marketing)​Non-interventional​2013​Women’s Health
    Pre-menstrual syndrome​Drug​III​Interventional​2011​Women’s Health
    Show more Request a Proposal
    palleos healthcare GmbH
    Welfenstraße 2
    65189 Wiesbaden | Germany
    info@palleos.com
    +49 (0) 611 – 950190 – 0
    +49 (0) 611 – 950190 – 29
    Clinical Services
    Regulatory Support Safety Feasibility Services MedSci Consulting and Excellence Clinical Study Management Biometrics
    Consulting Services
    Resource Library
    Blog Case Studies Industry Reports Palleos TV Press Releases
    Company
    About Us Career Leadership Team
    Contact Us
    © 2013 -  2024 palleos healthcare GmbH
    Privacy & Cookies Imprint & Legal